[{"data": {"name": "Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Michael A. Steinman", "@type": "Person"}, {"name": "Gary E. Rosenthal", "@type": "Person"}, {"name": "C. Seth Landefeld", "@type": "Person"}, {"name": "Daniel Bertenthal", "@type": "Person"}, {"name": "Peter J. Kaboli", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/224688/ioi90034_1326_1332.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Medical Association (AMA)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1001/archinternmed.2009.206", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCNmJNgbqg4yY-CTAPFirExUnr1-CDKTrXWcXQQ8R-CR4Np7ZkprVM4", "propertyID": "ISCC"}], "datePublished": "2009-07-27"}, "schema": "schema.org", "mediatype": "application/ld+json"}]